摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[4-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoic acid | 863767-93-5

中文名称
——
中文别名
——
英文名称
4-[4-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoic acid
英文别名
4-[4-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoic acid
4-[4-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoic acid化学式
CAS
863767-93-5
化学式
C17H18N4O3
mdl
——
分子量
326.355
InChiKey
YDCARMLEUJTVJZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    24.0
  • 可旋转键数:
    6.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    124.86
  • 氢给体数:
    4.0
  • 氢受体数:
    4.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-[4-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoic acidsodium hydroxide三乙胺氯甲酸异丁酯 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 58.5h, 生成 N-{4-[4-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)butyl]benzoyl}-L-glutamic acid
    参考文献:
    名称:
    Synthesis of Classical, Four-Carbon Bridged 5-Substituted Furo[2,3-d]pyrimidine and 6-Substituted Pyrrolo[2,3-d]pyrimidine Analogues as Antifolates
    摘要:
    We report, for the first time, the biological activities of four-carbon-atom bridged classical antifolates on dihydrofolate reductase (DHFR), thymidylate synthase (TS), and folylpolyglutamate synthetase (FPGS) as well as antitumor activity. Extension of the bridge homologation studies of classical two-carbon bridged antifolates, a 5-substituted 2,4-diaminofuro[2,3d]pyrimidine (1) and a 6-subsituted 2-amino-4-oxopyrrolo[2,3-d]pyrimidine (2), afforded two four-carbon bridged antifolates, analogues 5 and 6, with enhanced FPGS substrate activity and inhibitory activity against tumor cells in culture (EC50 <= 10(-7) M) compared with the two-carbon bridged analogues. These results support our original hypothesis that the distance and orientation of the side chain p-aminobenzoyl-L-glutamate moiety with respect to the pyrimidine ring are a crucial determinant of biological activity. In addition, this study demonstrates that, for classical antifolates that are substrates for FPGS, poor inhibitory activity against isolated target enzymes is not necessarily a predictor of a lack of antitumor activity.
    DOI:
    10.1021/jm058213s
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Classical, Four-Carbon Bridged 5-Substituted Furo[2,3-d]pyrimidine and 6-Substituted Pyrrolo[2,3-d]pyrimidine Analogues as Antifolates
    摘要:
    We report, for the first time, the biological activities of four-carbon-atom bridged classical antifolates on dihydrofolate reductase (DHFR), thymidylate synthase (TS), and folylpolyglutamate synthetase (FPGS) as well as antitumor activity. Extension of the bridge homologation studies of classical two-carbon bridged antifolates, a 5-substituted 2,4-diaminofuro[2,3d]pyrimidine (1) and a 6-subsituted 2-amino-4-oxopyrrolo[2,3-d]pyrimidine (2), afforded two four-carbon bridged antifolates, analogues 5 and 6, with enhanced FPGS substrate activity and inhibitory activity against tumor cells in culture (EC50 <= 10(-7) M) compared with the two-carbon bridged analogues. These results support our original hypothesis that the distance and orientation of the side chain p-aminobenzoyl-L-glutamate moiety with respect to the pyrimidine ring are a crucial determinant of biological activity. In addition, this study demonstrates that, for classical antifolates that are substrates for FPGS, poor inhibitory activity against isolated target enzymes is not necessarily a predictor of a lack of antitumor activity.
    DOI:
    10.1021/jm058213s
点击查看最新优质反应信息

文献信息

  • Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity
    作者:Yijun Deng、Yiqiang Wang、Christina Cherian、Zhanjun Hou、Steven A. Buck、Larry H. Matherly、Aleem Gangjee
    DOI:10.1021/jm8003366
    日期:2008.8.1
    diethyl-L-glutamate, and saponification afforded 2-5. Compounds 2-5 had negligible substrate activity for RFC but showed variably potent (nanomolar) and selective inhibitory activities toward Chinese hamster ovary cells that expressed FRalpha or FRbeta and toward FRalpha-expressing KB and IGROV1 human tumor cells. Inhibition of KB cell colony formation was also observed. Glycinamide ribonucleotide formyl transferase
    6-取代的经典吡咯并[2,3-d]嘧啶抗叶酸剂在杂环和苯甲酰-L-谷氨酸(分别为化合物2-5)之间具有三至六碳桥,由4-甲酰苯甲酸甲酯和与适当的三苯基的 Wittig 反应,然后还原并转化为 α-溴甲基酮。2,4-二基-4-氧代嘧啶与α-酮的环缩合、与L-谷氨酸二乙酯的偶联和皂化得到2-5。化合物 2-5 对 RFC 的底物活性可忽略不计,但对表达 FRalpha 或 FRbeta 的中国仓鼠卵巢细胞以及表达 FRalpha 的 KB 和 IGROV1 人类肿瘤细胞显示出不同的强效(纳摩尔)和选择性抑制活性。还观察到对KB细胞集落形成的抑制。甘酰胺核糖核苷酸甲酰转移酶 (GARFTase) 被鉴定为吡咯并 [2,3-d] 嘧啶的主要细胞内靶标。选择性 FR 靶向、缺乏 RFC 转运和 GARFTase 抑制导致有效抗肿瘤活性的综合特性是前所未有的,并保证将这些类似物开发为抗肿瘤剂。
  • Discovery of novel tumor-targeted near-infrared probes with 6-substituted pyrrolo[2,3-d]pyrimidines as targeting ligands
    作者:Yining Zhang、Zijun Luo、Lixiao Guo、Haofeng Zhang、Tongdan Su、Zhenzhen Tan、Qian Ren、Can Zhang、Yan Fu、Ruijuan Xing、Ran Guo、Xiaowei Shi、Huicai Guo、Yi Liu、Lei Wang
    DOI:10.1016/j.ejmech.2023.115914
    日期:2023.12
    fluorescent probes were designed and synthesized based on previously reported 6-substituted pyrrolo[2,3-d]pyrimidine antifolates. All newly synthesized probes showed specific FR binding in vitro, whereas GT-NIR-4 and GT-NIR-5 with a benzene and a thiophene ring, respectively, on the side chain of pyrrolo[2,3-d]pyrimidine exhibited better FR binding affinity than that of GT-NIR-6 with folic acid as targeting
    由于叶酸受体 (FRs) 在某些类型的癌症中过表达,因此已经开发了多种用于肿瘤检测的 FR 靶向荧光探针。然而,报道的探针几乎都具有相同的叶酸靶向配体,具有不同的荧光团和/或接头。在本研究中,基于先前报道的 6-取代吡咯并[2,3-d] 嘧啶抗叶酸酯设计并合成了一系列新型肿瘤靶向近红外 (NIR) 分子荧光探针。所有新合成的探针在体外均显示出特异性 FR 结合,而吡咯并[2,3-d]嘧啶侧链上分别带有苯和噻吩环的 GT-NIR-4 和 GT-NIR-5 表现出比以叶酸为靶向配体的 GT-NIR-6 更好的 FR 结合亲和力。GT-NIR-4 在 KB 荷瘤小鼠中也显示出高肿瘤摄取,具有良好的药代动力学特性和生物安全性。这项工作展示了用抗叶酸代替叶酸作为肿瘤靶向 NIR 探针的靶向配体的首次尝试。
查看更多

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 酸蓝129:1 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 芦可替尼杂质5 芦可替尼杂质3 芦可替尼杂质2 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 甲基6,7-二氢-5H-吡咯并[3,4-D]嘧啶-2-甲酸基酯 氰基酰胺,(1-甲基-2-吡咯烷亚基)-(9CI) 杂质TFTB 替诺福韦杂质113 托法替布杂质ZJT2-I 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼杂质9 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 培美曲塞杂质 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-C]嘧啶-4-腈 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 化合物PFE-360 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼